Brian Cutting

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• University of Basel14.6%
• Alnylam Pharmaceuticals (United States)13.7%
• Washington University in St. Louis9.9%
• Pfizer (United States)9.7%
• Centre National de la Recherche Scientifique7.9%
• Novartis (Switzerland)7.1%
• Other37.1%

Fields

• Biochemistry, Genetics and Molecular Biology66.7%
• Medicine18.7%
• Agricultural and Biological Sciences4.6%
• Chemistry3.2%
• Immunology and Microbiology2.3%
• Materials Science2.3%
• Other2.3%

Topics

• RNA Interference and Gene Delivery12.2%
• Glycosylation and Glycoproteins Research11.6%
• Monoclonal and Polyclonal Antibodies Research10.1%
• Chemical Synthesis and Analysis9.2%
• Escherichia coli research studies8.9%
• Advanced biosensing and bioanalysis techniques8%
• Other40.1%